These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 2500348

  • 1. Immunity to experimental infection with Leishmania major: generation of protective L3T4+ T cell clones recognizing antigen(s) associated with live parasites.
    Müller I, Louis JA.
    Eur J Immunol; 1989 May; 19(5):865-71. PubMed ID: 2500348
    [Abstract] [Full Text] [Related]

  • 2. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD, Heinzel FP, Shigekane VM, Fisher WL, Locksley RM.
    J Immunol; 1987 Aug 15; 139(4):1303-9. PubMed ID: 3112230
    [Abstract] [Full Text] [Related]

  • 3. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
    Moll H, Scollay R.
    Eur J Immunol; 1989 Feb 15; 19(2):307-14. PubMed ID: 2467816
    [Abstract] [Full Text] [Related]

  • 4. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
    Prina E, Lang T, Glaichenhaus N, Antoine JC.
    J Immunol; 1996 Jun 01; 156(11):4318-27. PubMed ID: 8666803
    [Abstract] [Full Text] [Related]

  • 5. Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice.
    Milon G, Titus RG, Cerottini JC, Marchal G, Louis JA.
    J Immunol; 1986 Feb 15; 136(4):1467-71. PubMed ID: 2418115
    [Abstract] [Full Text] [Related]

  • 6. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
    Liew FY, Dhaliwal JS.
    J Immunol; 1987 Jun 15; 138(12):4450-6. PubMed ID: 3295049
    [Abstract] [Full Text] [Related]

  • 7. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA, Ogunremi O, Menon JN.
    Behring Inst Mitt; 1997 Feb 15; (98):153-9. PubMed ID: 9382736
    [Abstract] [Full Text] [Related]

  • 8. Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection.
    Liew FY, Singleton A, Cillari E, Howard JG.
    J Immunol; 1985 Sep 15; 135(3):2102-7. PubMed ID: 3160786
    [Abstract] [Full Text] [Related]

  • 9. Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells.
    Bogdan C, Schröppel K, Lohoff M, Röllinghoff M, Solbach W.
    Eur J Immunol; 1990 Dec 15; 20(12):2533-40. PubMed ID: 1980108
    [Abstract] [Full Text] [Related]

  • 10. Exacerbation of experimental murine cutaneous leishmaniasis with CD4+ Leishmania major-specific T cell lines or clones which secrete interferon-gamma and mediate parasite-specific delayed-type hypersensitivity.
    Titus RG, Müller I, Kimsey P, Cerny A, Behin R, Zinkernagel RM, Louis JA.
    Eur J Immunol; 1991 Mar 15; 21(3):559-67. PubMed ID: 1672641
    [Abstract] [Full Text] [Related]

  • 11. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD, Locksley RM, Tubbs C, Raff HV.
    J Immunol; 1986 Jan 15; 136(2):655-61. PubMed ID: 3079789
    [Abstract] [Full Text] [Related]

  • 12. Protection against Leishmania major in BALB/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes.
    Scott P, Caspar P, Sher A.
    J Immunol; 1990 Feb 01; 144(3):1075-9. PubMed ID: 2295814
    [Abstract] [Full Text] [Related]

  • 13. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
    Titus RG, Lima GC, Engers HD, Louis JA.
    J Immunol; 1984 Sep 01; 133(3):1594-600. PubMed ID: 6205088
    [Abstract] [Full Text] [Related]

  • 14. Prophylactic immunization against experimental leishmaniasis. VI. Comparison of protective and disease-promoting T cells.
    Liew FY, Hodson K, Lelchuk R.
    J Immunol; 1987 Nov 01; 139(9):3112-7. PubMed ID: 3312413
    [Abstract] [Full Text] [Related]

  • 15. Isolation of protective T cells from BALB/cJ mice chronically infected with Leishmania donovani.
    Holaday B, Sadick MD, Pearson RD.
    J Immunol; 1988 Sep 15; 141(6):2132-7. PubMed ID: 3262649
    [Abstract] [Full Text] [Related]

  • 16. T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana.
    Torrentera FA, Glaichenhaus N, Laman JD, Carlier Y.
    Infect Immun; 2001 Jan 15; 69(1):617-21. PubMed ID: 11119565
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice.
    Titus RG, Ceredig R, Cerottini JC, Louis JA.
    J Immunol; 1985 Sep 15; 135(3):2108-14. PubMed ID: 3926895
    [Abstract] [Full Text] [Related]

  • 18. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis.
    Stern JJ, Oca MJ, Rubin BY, Anderson SL, Murray HW.
    J Immunol; 1988 Jun 01; 140(11):3971-7. PubMed ID: 3131421
    [Abstract] [Full Text] [Related]

  • 19. Murine epidermal Langerhans cells are potent stimulators of an antigen-specific T cell response to Leishmania major, the cause of cutaneous leishmaniasis.
    Will A, Blank C, Röllinghoff M, Moll H.
    Eur J Immunol; 1992 Jun 01; 22(6):1341-7. PubMed ID: 1601029
    [Abstract] [Full Text] [Related]

  • 20. Involvement of specific Lyt-2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis.
    Titus RG, Milon G, Marchal G, Vassalli P, Cerottini JC, Louis JA.
    Eur J Immunol; 1987 Oct 01; 17(10):1429-33. PubMed ID: 3119350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.